Penson, P and Banach, M (2021) Nutraceuticals for the control of dyslipidemias in clinical practice. Nutrients, 13 (9). ISSN 2072-6643
|
Text
Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice.pdf - Published Version Available under License Creative Commons Attribution. Download (610kB) | Preview |
Abstract
Dyslipidaemias result in the deposition of cholesterol and lipids in the walls of blood vessels, chronic inflammation and the formation of atherosclerotic plaques, which impede blood flow and (when they rupture) result in acute ischaemic episodes. Whilst recent years have seen enormous success in the reduction of cardiovascular risk using conventional pharmaceuticals, there is increasing interest amongst patients and practitioners in the use of nutraceuticals to combat dyslipidaemias and inflammation in cardiovascular disease. Nutraceutical is a portmanteau term: ‘ceutical’ indicate pharmaceutical-grade preparations, and ‘nutra’ indicates that the products contain nutrients from food. Until relatively recently, little high-quality evidence relating to the safety and efficacy of nutraceuticals has been available to prescribers and policymakers. However, as a result of recent randomised-controlled trials, cohort studies and meta-analyses, this situation is changing, and nutraceuticals are now recommended in several mainstream guidelines relating to dyslipidaemias and atherosclerosis. This article will summarise recent clinical-practice guidance relating to the use of nutraceuticals in this context and the evidence which underlies them. Particular attention is given to position papers and recommendations from the International Lipid Expert Panel (ILEP), which has produced several practical and helpful recommendations in this field.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 0908 Food Sciences, 1111 Nutrition and Dietetics |
Subjects: | T Technology > TX Home economics > TX341 Nutrition. Foods and food supply R Medicine > RM Therapeutics. Pharmacology R Medicine > RV Botanic, Thomsonian, and eclectic medicine |
Divisions: | Pharmacy & Biomolecular Sciences |
Publisher: | MDPI AG |
Date Deposited: | 31 Aug 2021 09:52 |
Last Modified: | 04 Sep 2021 05:06 |
DOI or ID number: | 10.3390/nu13092957 |
URI: | https://researchonline.ljmu.ac.uk/id/eprint/15414 |
View Item |